|
|
||||||||
The First Department of Physiology, Shinshu University School of Medicine, Matsumoto 390-8621, Japan
| |
ABSTRACT |
|---|
|
|
|---|
A mode of action of endothelin (ET) on
spontaneous contractions was investigated in ring preparations of
isolated bovine mesenteric lymphatics. ET-1 at concentrations between
10
10 and
10
9 M caused a
dose-dependent increase in the frequency of spontaneous contractions.
The specific ETA-receptor
antagonist BQ-123 (5 × 10
7 M) caused a significant
inhibition of the ET-1-induced positive chronotropic effect in the ring
preparations with and without the endothelium. Mechanical denudation of
the lymphatic endothelial cells produced a significant potentiation of
the ET-induced positive chronotropic effect. BQ-3020
(10
8-10
7
M), a selective ETB-receptor
agonist, induced dose dependently negative chronotropic and inotropic
effects on the spontaneous contractions in the ring preparations with
intact endothelium. Mechanical removal of the endothelium caused a
significant reduction of the BQ-3020-induced negative chronotropic and
inotropic effects. The ET-1-induced positive chronotropic effect was
potentiated by pretreatment with
N
-nitro-L-arginine methyl ester
(L-NAME)
(10
5 M) but unaffected by
aspirin (10
5 M). Additional
treatment with L-arginine
(10
4 M) completely reversed
the L-NAME-mediated potentiation
of the ET-induced chronotropic effect. These results suggest that
stimulation of ETA receptors on
the lymphatic smooth muscles causes a positive chronotropic effect on
the spontaneous contractions, and stimulation of
ETB receptors on the lymphatic
endothelial cells induces a release of nitric oxide, which results in
the chronotropic and inotropic effects on spontaneous contractions in
isolated bovine mesenteric lymphatics.
lymphatics; nitric oxide
| |
INTRODUCTION |
|---|
|
|
|---|
THE EFFECTS OF ENDOTHELIN (ET) on blood vessels have been widely investigated (27). The ETs are known to be a family of peptides, which include endothelin-1, -2, and -3 (ET-1, ET-2, and ET-3) (34). Two ET receptors have also been cloned, the ETA receptor, which preferentially binds ET-1 (1), and the ETB receptor, which has an equal affinity for all isoforms of ETs (28). The ETA and ETB receptors are expressed on vascular smooth muscles to mediate contraction, whereas endothelial cells mainly express ETB receptors (4). An activation of the endothelial ETB receptors causes a release of prostacyclin (PGI2) (5) or nitric oxide (NO) from the endothelial cells, which results in a marked vasodilation (33).
On the other hand, little information except for the following papers exists regarding potential effects of ETs on the lymphatic vessels. ET-1 induces a contraction of isolated rat mesenteric (8) and isolated porcine tracheobronchial lymph vessels (25) and also increases intraluminal pressure of prenodal lymph vessels in the canine forelimb (6). Cultured human umbilical vein endothelial cells are also known to release ET-1 predominantly into an abluminal compartment rather than an apical (luminal) compartment (30). The findings may suggest a possibility that ET-1 diffuses mainly in the interstitial space and then moves into lymph vessels.
The lymphatic system plays an important role in the overall homeostasis of body fluids. The mechanisms by which those functions are carried out depend on active and passive driving forces, as well as on the rate of lymph production in organs and tissues. The active driving force is due to the intrinsic contractility of the lymph vessels.
Bovine mesenteric lymphatics show spontaneous intrinsic contractions that produce the active driving force for centripetal propulsion of lymph (13, 19). The frequency and amplitude of the spontaneous contractions are modified by nerves (21), humoral factors (2, 31), and mechanical forces (14). Therefore the present study was designed to investigate the mode of action of ET on the spontaneous contractions in the isolated bovine mesenteric lymphatics with special reference to an endogenous NO and vasodilatory prostanoids.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Tissue preparations. One hundred and thirty lymph vessels (2-4 mm in outer diameter) were dissected quickly from 29 fresh mesenteries, usually 20-30 min after the cattle had been slaughtered. Ring segments, 5-mm long, were prepared from the isolated lymph vessels after removal of surrounding adipose and connective tissues.
Measurement of mechanical activity. Each of the lymphatic ring preparations was suspended in a 10-ml organ bath. The organ bath was perfused at a constant rate of 4 ml/min with Krebs-bicarbonate solution. The solution was kept at 37.0 ± 0.5°C through a heat exchanger and aerated with 95% O2-5% CO2 to give a pH of 7.4. The composition of the Krebs solution was as follows (in mM): 120.0 NaCl, 5.9 KCl, 25.0 NaHCO3, 1.2 NaH2PO4, 2.5 CaCl2, 1.2 MgCl2, and 5.5 glucose. Two thin silk strings were run through the lumen of a ring preparation and formed into two rings. With the use of a dissecting microscope, we inserted the strings gently through the lumen of the ring preparation to avoid damaging the endothelial cells. The presence of the intact endothelial cells was also confirmed histologically by a silver-staining procedure (24) or pharmacologically by an administration of acetylcholine (36). One string was connected to the lever of a force-displacement transducer (Shinko Tsushin UL-10-120, Tokyo, Japan) and the other to the bottom of the organ bath. The isometric tension detected by the transducer was amplified and recorded on a direct-writing oscillograph (Sanei Sokki, 8 K, Tokyo, Japan). The resting tension of each ring preparation was set at 0.2-0.5 g, being optimal for the appearance of spontaneous contractions in the isolated bovine mesenteric lymph vessels (31, 36).
Experimental protocols. All lymphatic ring preparations were allowed to equilibrate for 60-90 min in the oxygenated bathing medium before we began the experiments. After spontaneous contractions reached a constant rate of 1-3 beats/min, the following experimental protocols were carried out.
The effects of ET-1 on the spontaneous contractions were observed in
some ring preparations of the isolated bovine mesenteric lymph vessels.
ET-1 was added directly to the organ bath in a single dose with a
microsyringe. The doses of the drug were expressed in terms of the base
and at the final organ bath concentrations. Thus each concentration of
ET-1 was washed out between the doses. The concentration of ET-1 was
increased separately from 1.0 × 10
10, 3.0 × 10
10, 5.0 × 10
10, and 7.0 × 10
10 to 1.0 × 10
9 M. A single
concentration of ET-1 was administered at 45-min intervals to prevent
tachyphylaxis. A concentration-response curve for ET-1 was obtained in
each lymphatic ring preparation. Each experiment was completed in up to
3-4 h. Some lymphatic preparations responded repeatedly by an
administration of acetylcholine to evaluate time-dependent changes in
the mechanical reactivity of the lymphatic endothelial and smooth
muscle cells (time control). The mechanical sensitivity of
the lymphatic ring preparations was confirmed to be stable over this
time period.
When the effect of a certain antagonist on the ET-1-induced response
was examined, the lymphatic ring preparations were pretreated for at
least 30 min with the antagonist before the responses to ET-1 were
observed. In this case, one or two doses of ET-1 were investigated in
one lymphatic preparation. Thus each experiment was completed in up to
3-4 h. No significant change in the responses of the ring
preparations to acetylcholine was observed over this time period. The
concentration-response curves for ET-1 were compared in the lymphatic
ring preparations before and after the treatment with BQ-123 (5 × 10
7 M), a selective
ETA-receptor antagonist. In some
experiments, controls were run with no antagonist to observe
time-dependent changes in the sensitivity of the lymphatic ring
preparations to ET-1. A single dose-response curve for BQ-3020, a
selective ETB-receptor agonist,
was also constructed in some lymphatic ring preparations in the same
manner as those obtained with ET-1.
The responses to ET-1 and BQ-3020 were also examined in some lymphatic ring preparations from which endothelial cells had been mechanically removed by rubbing the intimal surface with a Krebs-wetted filter paper. The absence of endothelial cells was confirmed histologically by a silver-staining procedure (24) or pharmacologically by an administration of acetylcholine (36).
To examine roles of endogenous prostanoids and NO in the ET-1-induced
responses of the lymphatic ring preparations, effects of
acetylsalicylic acid (aspirin,
10
5 M), a cyclooxygenase
inhibitor, N
-nitro-L-arginine
methyl ester (L-NAME,
10
5 M), a NO synthesis
inhibitor, and L-NAME + L-arginine
(10
4 M) on the ET-1-induced
responses were investigated in the other endothelium-intact lymphatic
ring preparations.
Drugs. The drugs used were the following: endothelin-1 (human) (Peptide Institute, Osaka, Japan), BQ-123 Na, BQ-3020 (Banyu Pharmaceutical, Tsukuba, Japan), acetylcholine chloride (Daiichi Seiyaku, Tokyo, Japan), aspirin, L-NAME hydrochloride, and L-arginine hydrochloride (Sigma, St. Louis, MO).
Statistics. Effects of the agonists on the spontaneous contractions in the lymphatic ring preparations are evaluated with relative changes in the contraction period between the spontaneous contractions. The relative change in the contraction period is defined as T2/T1, where T1 and T2 are the average of the five contraction periods between spontaneous contractions before administration of the agonist and during the agonist-induced maximal response, respectively. All results in the text, figures, and tables are expressed as means ± SE. The two-tailed Student's t-test for paired or unpaired data or a one- or two-way ANOVA followed by the Scheffé's test was used to investigate for statistical significance between the groups. Differences between the groups were considered significant at P < 0.05.
| |
RESULTS |
|---|
|
|
|---|
Effects of ET-1 on spontaneous
contractions. Administration of ET-1
(10
10-10
9
M) caused a dose-related acceleration of the contraction period between
spontaneous contractions in bovine isolated mesenteric lymphatics (Fig.
1). Higher concentrations of ET-1 (>7 × 10
10 M) induced a
small rise of the basal tone in a dose-dependent manner. Repeated
administration (3-4 h) of ET-1 (7 × 10
10 M) at 45-min intervals
caused no significant reduction in the ET-1-induced positive
chronotropic and inotropic effects on the spontaneous contractions
(Fig. 2). Such dose-response curves for ET-1 in the lymphatic ring preparations with intact endothelium are
summarized in Fig. 4, A and
B.
|
|
Effects of BQ-123 on ET-1-induced positive
chronotropic effect. Figure
3 shows a representative recording of
effects of 5 × 10
7 M
BQ-123 on the ET-1 (5 × 10
10 M)-induced positive
chronotropic and inotropic effects on the spontaneous contractions in
the lymphatic ring preparations. The effects of BQ-123 on the
ET-1-induced positive chronotropic effect in the ring preparations with
intact endothelium are summarized in Fig.
4A
(n = 6). Pretreatment with BQ-123 (5 × 10
7 M) caused a
significant reduction of the ET-1-induced positive chronotropic effect
on the spontaneous contractions (Fig.
4A).
|
|
The denudation of the lymphatic endothelial cells caused a significant
potentiation of the ET-1-induced positive chronotropic effect on the
spontaneous contractions (Fig. 4B).
However, the denudation per se produced no significant effect on the
basal frequency of spontaneous contractions in the ring
preparations (Table 1).
|
The effects of BQ-123 on the ET-1-induced chronotropic effect were also
examined in the endothelium-denuded ring preparations (n = 6) (Fig.
4C). Pretreatment with BQ-123 (5 × 10
7 M)
significantly reduced the ET-1-induced chronotropic effect in the
lymphatic ring preparations without endothelium (Fig.
4C). An administration of 5 × 10
7 M BQ-123, however,
caused no significant effect on the basal frequency of spontaneous
contractions in the lymphatic ring preparations (Table 1).
Effects of BQ-3020 on spontaneous
contractions. Figure 5
demonstrates representative recordings of effects of a specific
ETB agonist (BQ-3020) on the
spontaneous contractions in the lymphatic ring preparations with or
without intact endothelium. In Fig. 5A, BQ-3020 at a concentration of 5 × 10
8 M caused a
marked transient increase in the contraction periods and decrease in
the amplitude of spontaneous contractions in the lymphatic ring
preparations with the endothelium. In Fig.
5B, mechanical denudation of the
lymphatic endothelial cells caused a significant inhibition of the
BQ-3020-induced negative chronotropic and inotropic effects on
spontaneous contractions.
|
Such effect of BQ-3020 on the contraction period between spontaneous
concentrations is summarized in Fig. 6.
BQ-3020 at concentrations ranging from
10
8 to
10
7 M caused a
dose-dependent increase in the contraction period between spontaneous
contractions in the lymphatic ring preparations with intact endothelium
(relative ratio of the contraction periods before to after the
administration of BQ-3020: 1.03 ± 0.02 at 10
8 M BQ-3020 and 1.39 ± 0.07 at 10
7 M
BQ-3020, n = 8;
P < 0.05). The endothelial
denudation in the lymphatic ring preparations caused a significant
reduction of the dose-response curve for BQ-3020
(n = 8) (Fig. 6).
|
Effect of aspirin, L-NAME, and
L-NAME + L-arginine on ET-1-induced positive
chronotropic effect.
Pretreatment with 10
5 M
aspirin did not alter the ET-1-induced positive chronotropic effect on
the spontaneous contractions in the lymphatic ring preparations
(n = 6) (Table
2). On the other hand, the ET-1-induced
positive chronotropic effect on spontaneous contractions in the
lymphatic ring preparations was significantly potentiated by the
pretreatment with 10
5 M
L-NAME, and an additional
treatment with 10
4 M
L-arginine significantly
inhibited the L-NAME-induced
potentiation of the ET-1-induced chronotropic effect
(n = 6) (Fig.
7).
|
|
5 M
L-NAME itself produced a
significant increase of the basal frequency of the spontaneous
contractions in the lymphatic ring preparations (Table 1). An
additional treatment with
10
4 M
L-arginine partly reversed the
L-NAME-induced increase of the basal frequency of the spontaneous contractions (Table 1).
| |
DISCUSSION |
|---|
|
|
|---|
The transport of lymph depends on the passive and active driving forces as well as the rate of lymph production in organs and tissues (19). It is clear that the architecture of lymph vessels with the presence of valves allows lymph transport to occur by passive driving forces such as external compression of the vessels by adjacent tissue (32). The active driving mechanism, which may have a significant role in the centripetal propulsion of lymph, is due to the intrinsic spontaneous contractions of the lymph vessels (11, 19). In bovine mesenteric lymphatics in which smooth muscles are well developed in the wall (20), the frequency and amplitude of the spontaneous contractions significantly affect the active driving forces (18, 19). The frequency and amplitude of the spontaneous contractions in the bovine mesenteric lymph vessels are known to be regulated by several vasoactive substances, such as norepinephrine, 5-hydroxytryptamine, histamine, acetylcholine, prostaglandins (PGs), and bradykinin (13, 18, 36). Especially low concentrations of acetylcholine produce negative chronotropic and inotropic effects on the spontaneous contractions in the bovine mesenteric lymphatics, the responses of which may be mediated by NO released from the endothelial cells through activation of low-affinity muscarinic receptors (36).
ET-1 is a very potent and long-acting vasoconstrictor that is mainly produced by endothelial cells of blood and lymph vessels (25, 34). Reeder and Ferguson (25) reported that ET-1 induced tonic contractions in isolated porcine tracheobronchial lymph vessels that were attenuated by ETA and/or ETB blockers. No study, however, had been carried out to investigate the effects of ETs on the spontaneous contractions of isolated lymph vessels in vitro.
In the present experiments, ET-1 produced a dose-dependent decrease of the contraction period between spontaneous contractions in bovine isolated mesenteric lymphatics, which were attenuated by the pretreatment with BQ-123 (Fig. 4A). The same concentration of BQ-123 also significantly reduced the ET-1-induced positive chronotropic effect on the spontaneous contractions in the lymphatic ring preparations without intact endothelium (Fig. 4C). The findings suggest that excitation of ETA receptors on the lymphatic smooth muscle cells may contribute, in part, to the increase of the frequency of spontaneous contractions in bovine isolated mesenteric lymphatics.
Another important aspect of the present study is that the responses of ET agonists, including ET-1 and BQ-3020, appear to be quite transient and less tachyphylaxic compared with the previous studies of isolated blood and lymph vessels in vitro (8, 25, 34). The difference may be, in part, explained by following the present experimental properties used: 1) we used a specialized organ bath system that was perfused continuously by a Krebs solution at a constant rate of 4 ml/min during the experiments, 2) we directly administered a single dose of ET agonists into the organ bath system to make up dose-response curves for the agonists, and 3) we adopted low concentrations of ET agonists to investigate the effects of the drugs on the spontaneous contractions in the lymphatic ring preparations.
Vascular endothelial cells can release vasodilatory mediators (10), such as NO (23) and/or PGs (3). Stimulation of ETB receptors on endothelial cells of blood vessels is known to release endogenous NO and/or PGs, which contribute to a relaxation of vascular smooth muscles (5, 33). Acetylcholine-induced endogenous NO-mediated relaxations are shown in the canine isolated thoracic duct (22) and porcine isolated hepatic lymph vessels (12). Histamine and norepinephrine also induce a release of NO from porcine tracheobronchial and mesenteric lymph vessels (26). Recently, rat lymphatic endothelial cells were demonstrated to release both NO and PGs, which regulate the vasomotor activity of the collecting lymph vessels (16).
The present finding that endothelial denudation caused a significant
potentiation of the ET-1-induced positive chronotropic effect on the
spontaneous contractions (Fig. 4B)
may be compatible with a hypothesis that endothelium-derived substances
released by ET-1 contribute, in part, to attenuate the chronotropic
effect in the lymphatic ring preparations. The hypothesis may be
strongly supported by the finding that an
ETB-receptor agonist BQ-3020 (10
8-10
7
M) caused a dose-dependent increase of the contraction period between
spontaneous contractions in the lymph vessels (Fig. 6). In addition,
removal of the lymphatic endothelium caused a significant inhibition of
the BQ-3020-induced negative chronotropic effect on spontaneous
contractions (Figs. 5 and 6). Pretreatment with 10
5 M aspirin, the
concentration of which is known to inhibit cyclooxygenase significantly
in the isolated blood vessels (29), did not affect the ET-1-induced
positive chronotropic effect (Table 2), suggesting that prostacyclin
and the other prostanoids did not play an important role in the
ET-1-induced positive chronotropic effect in the bovine isolated
mesenteric lymph vessels.
On the other hand, pretreatment with
10
5 M
L-NAME, the concentration of which was confirmed
to inhibit specifically the production of endothelium-derived NO (17),
significantly potentiated the ET-1-induced positive chronotropic effect
in the lymphatic ring preparations (Fig. 7). Additional treatment with
10
4 M
L-arginine significantly
reversed the L-NAME-induced
inhibition of the ET-1-induced chronotropic effect. Also, it is well
known that endogenous NO produces negative chronotropic and inotropic effects on the spontaneous contractions in the bovine isolated mesenteric lymph vessels (36). These findings and evidence strongly suggest that ETB receptors may be
located on the lymphatic endothelial cells and that the stimulation of
the ETB receptors produces a negative chronotropic effect on spontaneous contractions in the isolated lymph vessels via a release of endogenous NO from the lymphatic endothelial cells.
In conclusion, the present study suggests that there are ETA receptors on the lymphatic smooth muscle cells and ETB receptors on the lymphatic endothelial cells in bovine mesenteric lymph vessels. Stimulation of the ETA receptors elicits the positive chronotropic effect on spontaneous contractions, and stimulation of ETB receptors induces a release of NO, which results in a decrease of the frequency and amplitude of spontaneous contractions in the lymph vessels.
However, further investigations will be needed in the future to evaluate physiological and pathophysiological roles in low concentrations of ET-induced positive and negative chronotropic effects on the spontaneous contractions in bovine mesenteric lymph vessels. Physiological and pathophysiological roles of endothelins in the blood and the lymphatic system are still unclear. One reason is that circulating endothelin levels in normal and pathological states (1-25 pM) are much lower than the concentrations necessary to elicit contractions of blood vessels in vivo (0.1-50 nM) or produce a positive chronotropic effect on spontaneous contractions in lymph vessels (0.1-1 nM) (9, 15). Because endothelin is preferentially secreted at the abluminal face of the endothelium (30), however, it may accumulate in tissues and lead to local concentrations that are much higher than in the blood circulation. Thus the concentrations of ETs in tissues and lymph in physiological and pathophysiological conditions may be higher than those measured in the plasma. In addition, activated macrophages in inflammation (7) and endothelin-secreting tumors (35) are well known to facilitate expression of mRNA for ET-1 and production of ET-1 protein and then secretion of the ET-1. It may be reasonable to hypothesize that a high concentration of ET in the lymph in the pathophysiological situation such as inflammation or the ET-secreting tumor seems to modulate lymph transport. Low concentrations of ET (0.1-1 nM) in the lymph may lead to increased lymph flow and resulting dehydration of the tissue. On the other hand, high concentrations of ET (>1 nM) in the lymph seem to cause a spasm of lymphatic smooth muscles, which may lead to decreased lymph flow and resulting edema of the tissue.
| |
FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: T. Ohhashi, The 1st Deptartment of Physiology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan (E-mail: ohhashi{at}sch.md.shinshu-u.ac.jp).
Received 2 September 1998; accepted in final form 31 March 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Arai, H.,
S. Hori,
I. Aramori,
H. Ohkubo,
and
S. Nakanishi.
Cloning and expression of a cDNA encoding an endothelin receptor.
Nature
348:
730-732,
1990[Medline].
2.
Azuma, T.,
T. Ohhashi,
and
I. C. Roddie.
Bradykinin-induced contractions of bovine mesenteric lymphatics.
J. Physiol. (Lond.)
342:
217-227,
1983
3.
Beetens, J. R.,
C. V. Hove,
M. Rampart,
and
A. G. Herman.
Acetylcholine stimulates the release of prostacyclin by rabbit aorta endothelium.
J. Pharm. Pharmacol.
35:
251-252,
1983[Medline].
4.
Clozel, M.,
G. A. Gray,
V. Breu,
B. M. Löffler,
and
R. Osterwalder.
The endothelin ETB receptor mediates both vasodilation and vasoconstriction.
Biochem. Biophys. Res. Commun.
186:
867-873,
1992[Medline].
5.
De Nucci, G.,
R. Thomas,
J. P. D'Orleans,
E. Antunes,
C. Walder,
and
T. D. Warner.
Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium derived relaxing factor.
Proc. Natl. Acad. Sci. USA
85:
9797-9800,
1988
6.
Dobbins, D. E.,
and
J. M. Dabney.
Endothelin-mediated constriction of prenodal lymphatic vessels in the canine forelimb.
Regul. Pept.
35:
81-91,
1991[Medline].
7.
Ehrenreich, H.,
R. W. Anderson,
C. H. Fox,
P. Rieckmann,
G. S. Hoffman,
W. D. Travis,
J. E. Coligan,
J. H. Kehrl,
and
A. S. Fauci.
Endothelins, peptides with potent vasoactive properties, are produced by human macrophages.
J. Exp. Med.
172:
1741-1748,
1990
8.
Fortes, Z. B.,
R. Scivoletto,
and
J. Garcia-Leme.
Endothelin-1 induces potent constriction of lymphatic vessels in situ.
Eur. J. Pharmacol.
170:
69-73,
1989[Medline].
9.
Frelin, C.,
and
D. Guedin.
Why are circulating concentrations of endothelin-1 so low?
Cardiovasc. Res.
28:
1613-1622,
1994
10.
Furchgott, R. F.,
and
J. V. Zawadzki.
The obligatory role if endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.
Nature
288:
373-376,
1980[Medline].
11.
Hall, J. G.,
B. Morris,
and
G. Woolley.
Intrinsic rhythmic propulsion of lymph in the unanaesthetized sheep.
J. Physiol. (Lond.)
180:
336-349,
1965
12.
Hashimoto, S.,
Y. Kawai,
and
T. Ohhashi.
Effects of vasoactive substances on the pig isolated hepatic lymph vessels.
J. Pharmacol. Exp. Ther.
269:
482-488,
1994
13.
Mawhinney, H. J. D.,
and
I. C. Roddie.
Spontaneous activity in isolated bovine mesenteric lymphatics.
J. Physiol. (Lond.)
229:
339-345,
1973
14.
McHale, N. G.,
and
I. C. Roddie.
The effect of transmural pressure on pumping activity in isolated bovine mesenteric lymphatic vessels.
J. Physiol. (Lond.)
261:
255-269,
1976
15.
Miyasaka, N.,
Y. Hirata,
K. Ando,
K. Sato,
H. Morita,
M. Shichiri,
K. Kanno,
K. Tomita,
and
F. Marumo.
Increased production of endothelin-1 in patients with inflammatory arthritides.
Arthritis Rheum.
35:
397-400,
1992[Medline].
16.
Mizuno, R.,
A. Koller,
and
G. Kaley.
Regulation of the vasomotor activity of lymph microvessels by nitric oxide and prostaglandins.
Am. J. Physiol.
274 (Regulatory Integrative Comp. Physiol. 43):
R790-R796,
1998
17.
Moncada, S.,
R. M. J. Palmer,
and
E. A. Higgs.
Nitric oxide: physiology, pathophysiology, and pharmacology.
Pharmacol. Rev.
43:
107-142,
1991.
18.
Ohhashi, T.
Regulation of motility of small collecting lymphatics.
In: Advances in Microcirculation. Interstitial-Lymphatic Liquid, and Solute Movement, edited by N. C. Staub,
J. C. Hogg,
and A. R. Hargens. Basel: Karger, 1987, vol. 13, p. 171-183.
19.
Ohhashi, T.,
T. Azuma,
and
M. Sakaguchi.
Active and passive mechanical characteristics of bovine mesenteric lymphatics.
Am. J. Physiol.
239 (Heart Circ. Physiol. 8):
H88-H95,
1980.
20.
Ohhashi, T.,
S. Fukushima,
and
T. Azuma.
Vasa vasorum within the media of bovine mesenteric lymphatics.
Proc. Soc. Exp. Biol. Med.
154:
582-586,
1977[Medline].
21.
Ohhashi, T.,
N. G. McHale,
I. C. Roddie,
and
K. D. Thornbury.
Electrical field stimulation as a method of stimulating nerve or smooth muscle in isolated bovine mesenteric lymphatics.
Pflügers Arch.
388:
221-226,
1980[Medline].
22.
Ohhashi, T.,
and
N. Takahashi.
Acetylcholine-induced release of endothelium-derived relaxing factor from lymphatic endothelial cells.
Am. J. Physiol.
260 (Heart Circ. Physiol. 29):
H1172-H1178,
1991
23.
Palmer, R. M. J.,
D. S. Ashton,
and
S. Moncada.
Vascular endothelial cell synthesize nitric oxide from L-arginine.
Nature
333:
664-666,
1988[Medline].
24.
Poole, J. C. F.,
A. G. Sanders,
and
H. W. Florey.
The regeneration of aortic endothelium.
J. Pathol. Bacteriol.
75:
133-143,
1958[Medline].
25.
Reeder, L. B.,
and
M. K. Ferguson.
Endothelin-1 synthesis and receptor-mediated activity in porcine lymph vessels.
J. Surg. Res.
63:
215-219,
1996[Medline].
26.
Reeder, L. B.,
L. H. Yang,
and
M. K. Ferguson.
Modulation of lymphatic spontaneous contractions by EDRF.
J. Surg. Res.
56:
620-625,
1994[Medline].
27.
Rubanyi, G. M.,
and
M. A. Polokoff.
Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology.
Pharmacol. Rev.
46:
325-415,
1994[Medline].
28.
Sakurai, T.,
M. Yanagisawa,
Y. Takuwa,
H. Miyazaki,
S. Kimura,
K. Goto,
and
T. Masaki.
Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor.
Nature
348:
732-735,
1990[Medline].
29.
Toda, N.,
and
M. Miyazaki.
Angiotensin-induced relaxation in isolated dog renal and cerebral arteries.
Am. J. Physiol.
240 (Heart Circ. Physiol. 9):
H247-H254,
1981.
30.
Wagner, O. F.,
G. Christ,
J. Wojta,
H. Vierhapper,
S. Parzer,
P. J. Nowotny,
B. Schneider,
W. Waldhäusl,
and
B. R. Binder.
Polar secretion of endothelin-1 by cultured endothelial cells.
J. Biol. Chem.
267:
16066-16068,
1992
31.
Watanabe, N.,
Y. Kawai,
and
T. Ohhashi.
Dual effects of histamine on spontaneous activity in isolated bovine mesenteric lymphatics.
Microvasc. Res.
36:
239-249,
1988[Medline].
32.
Webb, R. C.,
and
T. E. Starzl.
The effect of blood pressure pulsations on lymph pressure in large lymphatics.
Johns Hopkins Hosp. Bull.
93:
401-407,
1953.
33.
Whittle, B. J.,
J. Lopez Belmonte,
and
D. D. Rees.
Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation.
Br. J. Pharmacol.
98:
646-652,
1989[Medline].
34.
Yanagisawa, M.,
H. Kurihara,
S. Kimura,
Y. Tomobe,
M. Kobayashi,
Y. Mitsui,
Y. Yazaki,
K. Goto,
and
T. Masaki.
A novel potent vasoconstrictor peptide produced by vascular endothelial cells.
Nature
332:
411-415,
1988[Medline].
35.
Yokokawa, K.,
H. Tahara,
M. Kohno,
K.-i. Murakawa,
K. Yasunari,
K. Nakagawa,
T. Hamada,
S. Otani,
M. Yanagisawa,
and
T. Takeda.
Endothelin-secreting tumor.
J. Cardiovasc. Pharmacol.
17, Suppl. 7:
S398-S401,
1991.
36.
Yokoyama, S.,
and
T. Ohhashi.
Effects of acetylcholine on spontaneous contractions in isolated bovine mesenteric lymphatics.
Am. J. Physiol.
264 (Heart Circ. Physiol. 33):
H1460-H1464,
1993
This article has been cited by other articles:
![]() |
J. W. Breslin, N. Gaudreault, K. D. Watson, R. Reynoso, S. Y. Yuan, and M. H. Wu Vascular endothelial growth factor-C stimulates the lymphatic pump by a VEGF receptor-3-dependent mechanism Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H709 - H718. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mizuno, N. Ono, and T. Ohhashi Parathyroid hormone-related protein-(1-34) inhibits intrinsic pump activity of isolated murine lymph vessels Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H60 - H66. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |